SCHEMBL25203

SCHEMBL25203

O=C(O)CCC(=O)CCC(=O)O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.75
EGLN1 Q9GZT9 4/20 0.75
ALKBH5 Q6P6C2 1/20 0.75
SUCNR1 Q9BXA5 1/20 0.75
ACE P12821 1/20 0.71
GABRR1 P24046 1/20 0.65
KDM4E B2RXH2 3/20 0.58
KDM5C P41229 3/20 0.58
PHF8 Q9UPP1 3/20 0.58
KDM2A Q9Y2K7 3/20 0.58
KDM6B O15054 2/20 0.58
SLC22A6 Q4U2R8 1/20 0.53
SLC15A2 Q16348 1/20 0.53
MAPK1 P28482 1/20 0.53
SLC13A3 Q8WWT9 1/20 0.53
OR51E2 Q9H255 1/20 0.53
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
CYP2C19 P33261 1/20 0.52
TSHR P16473 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1603817 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL22464687 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL30203931 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL562396 1.00 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1ACE
Acetic Acid SCHEMBL9689708 0.89 EGLN1 (0.65) LMNAEGLN1ALKBH5SUCNR1ACE
SCHEMBL23002867 0.87 SLC22A6 (0.69) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL24696 0.87 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL4269135 0.87 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL21867134 0.87 LMNA (1.00) LMNAEGLN1ALKBH5SUCNR1ACE
Succinic Acid SCHEMBL3799615 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11951198-B2 Method and kit for processing hair LIW PATENT COMPANY LIMITED BY GUARANTEE (IE) 2024-04-09 US claimed
CN-115093794-B Polysilicon polishing composition and application thereof 万华化学集团电子材料有限公司 2023-10-13 CN claimed
CN-115093794-A Polysilicon polishing composition and application thereof 万华化学集团电子材料有限公司 2022-09-23 CN claimed
CN-112209891-A Preparation method and application of plasticizer 李世兵 2021-01-12 CN claimed
WO-2020081454-A1 MULTI-ENZYME-ACTIVATED IMAGING PROBES AND RELATED COMPOSITIONS AND METHODS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2020-04-23 WO claimed
CN-107698599-A The synthesis of pyridazine simultaneously [6,1 b] pyrrolo- [1,2 a] Quinazol derivative 江苏徐淮地区徐州农业科学研究所(江苏徐州甘薯研究中心) 2018-02-16 CN claimed
CN-102443316-B curable phase change inks containing crystalline polyester Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) 2016-02-03 CN claimed
US-8657430-B2 Curable phase change inks containing crystalline polyesters XEROX CORPORATION (US) 2014-02-25 US claimed
US-8613506-B2 2013-12-24 US claimed
CN-102443316-A Curable phase change inks containing crystalline polyesters XEROX CORP 2012-05-09 CN claimed
US-4978736-A Polyamideimide polymers SHELL OIL COMPANY (US) 1990-12-18 US claimed
US-4940801-A Spirodilactam derivatives SHELL OIL COMPANY (US) 1990-07-10 US claimed
US-4939251-A Novel spirolactones SHELL OIL COMPANY (US) 1990-07-03 US claimed
US-4927906-A Novel polyamideimide polymers SHELL OIL COMPANY (US) 1990-05-22 US claimed
US-4923708-A ARYL, ALKYL OR ALKENYL DICARBOXYLIC ACID, CONFECTIONERY, COATINGS NABISCO BRANDS, INC. (US) 1990-05-08 US claimed
US-4914176-A Poly(heterocyclic) polymers SHELL OIL COMPANY (US) 1990-04-03 US claimed
EP-0359340-A2 Spirodilactam polymers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1990-03-21 EP claimed
EP-0106206-B1 EPOXY RESIN COMPOSITION Hitachi Chemical Co., Ltd. (JP) 1988-03-16 EP claimed
US-4507460-A Epoxy resin composition HITACHI CHEMICAL CO., LTD. (JP) 1985-03-26 US claimed
EP-0106206-A1 Epoxy resin composition Hitachi Chemical Co., Ltd. (JP) 1984-04-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11951198-B2 Method and kit for processing hair KRT18, PHB1, BTD LMNA 280/4885EGLN1 3760/4885ALKBH5 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.